Ex-Biogen and MIT Exec Launches Writeinteractive to Help Solve 'Documentation Crisis' for Pharma and Beyond

Press Release (ePRNews.com) - CAMBRIDGE, Mass. - Aug 01, 2018 - A long-time Boston-area entrepreneur and technical writer today announced the formation of Writeinteractive, Inc. The start-up plans to help companies address the myriad of challenges associated with producing technical documentation in-house, especially for those in regulated industries.

Writeinteractive will provide technical writing and editing services, plus SharePoint development, web development, and knowledge management solutions on an outsourced basis. Companies struggling with managing the documentation load can contract with Writeinteractive to create and update standard operating procedures (SOPs), work instructions, user manuals, quick reference guides, SharePoint sites, knowledge base articles, and the like.

The company’s founder, Tim Brennan, said, “In over 30 years as a technical communications professional, I can’t remember a time when the need has been so great for content outsourcing. This is particularly true for regulated industries like BioTech, Life Sciences, and Finance who deal daily with having to produce a mountain of documentation to satisfy the stringent requirements of federal agencies.”

There is a documentation crisis looming, and many companies are falling behind on their audit responsibilities.

Tim Brennan

Founder, Writeinteractive, Inc.

As companies work to focus on product delivery that impacts their bottom line, the documentation required is often an afterthought. As a result, many companies often find themselves playing catch up to address customer concerns and findings by regulating authorities.

“There is truly a documentation crisis looming, and many companies are falling behind on their audit responsibilities. Writeinteractive is here to answer the call not just for technical writing but for related support services as well,” Brennan said.

The documentation upkeep required to meet federal regulations can be particularly daunting. In the Pharmaceutical and Medical Device industries for example, organizations must adhere to stringent GxP regulations like Good Documentation Practices (GDP), or they could face harsh penalties by the FDA. GDP governs the minimum standard operating procedure (SOP) requirements for computer systems, manufacturing processes, and laboratory practices, to name a few.

Brennan, who spent the last 10 years working at Biogen and before that MIT, said the company’s goal is ultimately to be a one-stop shop for technical content outsourcing—not just for regulated industries but for any type of company.

About Writeinteractive, Inc.

Writeinteractive is a professional services firm that is uniquely focused on helping innovative companies solve critical content challenges to meet real business goals. We are a trusted technical content services partner for some of the world’s greatest companies. These include Oracle-Siebel®, Merck-Millipore®, Thomson-Reuters®, and Biogen®. We work tirelessly to help these progressive organizations and others like them address the tough challenges associated with producing content in-house. Our business model is designed to support and streamline processes, deliver clear and concise content, improve professionalism, promote industry standards, and help companies adhere to strict quality and compliance regulations. For more information, please visit our website at www.writeinteractive.com

***

Source : Writeinteractiv
SHARE :  
Business Info :
WriteInteractive, Inc.

You may also like this  

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.